KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Accumulated Expenses: 2009-2024

Historic Other Accumulated Expenses for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $194.0 million.

  • Charles River Laboratories International's Other Accumulated Expenses rose 5.30% to $216.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $216.0 million, marking a year-over-year increase of 5.30%. This contributed to the annual value of $194.0 million for FY2024, which is 4.53% down from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Other Accumulated Expenses is $194.0 million, which was down 4.53% from $203.2 million recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Other Accumulated Expenses peaked at $204.6 million during FY2022, and registered a low of $102.5 million during FY2020.
  • In the last 3 years, Charles River Laboratories International's Other Accumulated Expenses had a median value of $203.2 million in 2023 and averaged $200.6 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first surged by 45.67% in 2022, then fell by 4.53% in 2024.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Other Accumulated Expenses stood at $102.5 million in 2020, then surged by 37.04% to $140.4 million in 2021, then surged by 45.67% to $204.6 million in 2022, then fell by 0.67% to $203.2 million in 2023, then dropped by 4.53% to $194.0 million in 2024.